Clinical Trial Manager

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: This is a unique opportunity for an experienced Clinical Operations Professional who has technical expertise in managing Phase I-III clinical trials in an industry setting and a strong knowledge of clinical operations, Good Clinical Practice (GCP) and U.S. Food and Drug Administration (FDA) regulatory requirements. Oncology experience is preferred. As the Clinical Trial Manager of Clinical Operations, initially reporting to the Director, Clinical Operations, you will be responsible for Contract Research Organization (CRO) oversight and execution of Revolution Medicines clinical studies. Specifically, you will be responsible for: Clinical operations functional activities related to the execution of assigned clinical trials based upon department and corporate goals and objectives. Management of clinical studies and vendors to ensure studies are completed on time, within budget and in compliance with Standard Operating Procedures (SOPs), FDA regulations and International Council for Harmonization (ICH)/ GCP guidelines. Identify, engage, and manage the activities of clinical CROs and other clinical study providers (e.g., core labs, Electronic Data Capture (EDC) provider, and independent contractors) to execute clinical trials. Reviewing and contributing to the development of study-specific documentation including clinical trial protocols, case report forms, study guides/manuals, informed consent forms and clinical database. Reviewing monitoring reports and other study documentation as required. Oversight of the collection and management of clinical trial documentation to be filed in the Trial Master File (TMF). Participation in team meetings and collaboration with other functional groups within the company (e.g., Clinical Development, Pharmacokinetics, Quantitative Sciences, Regulatory, QA, Finance, Legal, etc.) to achieve clinical study goals. Following up on assigned team action items and identification, escalation, and resolution of issues as needed. Collaboration with contracts specialist to review and negotiate Clinical Trial Agreements and site specific study budgets. Assessment of adequacy/feasibility of potential clinical investigators and sites including evaluating facilities, personnel, patient referral base, and adherence to GCP. Development of clinical study monitoring priorities and Monitoring Plan in conjunction with CRO. Conduct site visits (e.g., training visits, site initiation visits, monitoring visits), as required. Managing investigational product accountability and reconciliation process. Assistance with the preparation of safety, interim and final clinical study reports, and resolution of data discrepancies. Providing clinical trial support, mentoring, leadership, guidance, and direction to Clinical Research Associates (CRAs) assigned to clinical studies. Preparation and tracking of study participant enrollment projections vs. actuals and study budgets. Serving as primary clinical operations contact for internal and external (clinical sites, vendors, etc.) teams for assigned studies. Required Skills, Experience and Education: BS or MS degree with a minimum of 5 years clinical operations experience in the pharmaceutical or biotech industry, prefer…